Skip to main content
. 2020 Oct 29;11(4):603–627. doi: 10.1007/s13167-020-00226-x

Table 4.

ctDNA as a biomarker for neoplastic detection, predictive diagnostics and prognosis

Procedure Application Reference
Diagnosis Early detection [94, 133, 134, 136, 137]
Prediction Molecular heterogeneity [141]
Tumour dynamic assessment [128, 129, 142]
Determination of early treatment response [138, 139]
Acquired resistance [138, 140]
Prognosis Detection of marginal disease residues [143146]
Survival and recurrence rate [148]
Tumour load determination [149]